Jaromír Gumulec

520 total citations
17 papers, 311 citations indexed

About

Jaromír Gumulec is a scholar working on Genetics, Internal Medicine and Hematology. According to data from OpenAlex, Jaromír Gumulec has authored 17 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Internal Medicine and 4 papers in Hematology. Recurrent topics in Jaromír Gumulec's work include Venous Thromboembolism Diagnosis and Management (5 papers), Acute Ischemic Stroke Management (3 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). Jaromír Gumulec is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Acute Ischemic Stroke Management (3 papers) and Diabetic Foot Ulcer Assessment and Management (2 papers). Jaromír Gumulec collaborates with scholars based in Czechia, United States and Australia. Jaromír Gumulec's co-authors include Václav Procházka, Tomáš Jonszta, Daniel Czerný, Giannoula Klement, Petr Klement, Dana Šalounová, Jan Martínek, John W. Weisel, Chandrasekaran Nagaswami and Rustem I. Litvinov and has published in prestigious journals such as Blood, Stroke and The American Journal of the Medical Sciences.

In The Last Decade

Jaromír Gumulec

14 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaromír Gumulec Czechia 9 105 90 79 79 69 17 311
Qiankun Zhang China 8 80 0.8× 110 1.2× 99 1.3× 25 0.3× 69 1.0× 27 342
Z Mackiewicz Poland 13 125 1.2× 37 0.4× 101 1.3× 24 0.3× 17 0.2× 20 446
Jianlin Liu China 13 180 1.7× 25 0.3× 172 2.2× 58 0.7× 5 0.1× 46 573
H. J. Gallowitsch Austria 9 208 2.0× 13 0.1× 34 0.4× 50 0.6× 18 0.3× 10 456
Claudia Wojciechowski Germany 8 93 0.9× 48 0.5× 37 0.5× 128 1.6× 83 1.2× 11 387
Byung‐Joon Jeon South Korea 15 439 4.2× 34 0.4× 18 0.2× 54 0.7× 127 1.8× 57 637
Sebastian Butscheidt Germany 15 112 1.1× 13 0.1× 102 1.3× 64 0.8× 7 0.1× 31 532
Howard T. Wang United States 16 353 3.4× 98 1.1× 29 0.4× 88 1.1× 14 0.2× 24 501
G Coari Italy 12 151 1.4× 12 0.1× 33 0.4× 42 0.5× 27 0.4× 24 456
Mohamed Gadelkarim Egypt 10 53 0.5× 76 0.8× 45 0.6× 37 0.5× 80 1.2× 17 344

Countries citing papers authored by Jaromír Gumulec

Since Specialization
Citations

This map shows the geographic impact of Jaromír Gumulec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaromír Gumulec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaromír Gumulec more than expected).

Fields of papers citing papers by Jaromír Gumulec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaromír Gumulec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaromír Gumulec. The network helps show where Jaromír Gumulec may publish in the future.

Co-authorship network of co-authors of Jaromír Gumulec

This figure shows the co-authorship network connecting the top 25 collaborators of Jaromír Gumulec. A scholar is included among the top collaborators of Jaromír Gumulec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaromír Gumulec. Jaromír Gumulec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kuter, David J., Jiřı́ Mayer, Ross Baker, et al.. (2024). Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia. Blood Advances. 8(7). 1715–1724. 11 indexed citations
2.
Gumulec, Jaromír, et al.. (2023). Acquired haemophilia as a complicating factor in treatment of non-muscle invasive bladder cancer: A case report. World Journal of Clinical Cases. 11(22). 5338–5343.
3.
Plášek, Jiří, Jaromír Gumulec, Jan Máca, et al.. (2021). COVID-19 associated coagulopathy: Mechanisms and host-directed treatment. The American Journal of the Medical Sciences. 363(6). 465–475. 18 indexed citations
4.
Nagaswami, Chandrasekaran, et al.. (2020). Quantitative Morphology of Cerebral Thrombi Related to Intravital Contraction and Clinical Features of Ischemic Stroke. Stroke. 51(12). 3640–3650. 51 indexed citations
5.
Gumulec, Jaromír, et al.. (2019). Prevence tromboembolických komplikací v urologii. 23(3). 186–193.
6.
Mihályová, Jana, Tomáš Jelı́nek, Zdeněk Kořı́stek, et al.. (2019). Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment. Blood. 134(Supplement_1). 4757–4757.
7.
Kozubík, Kateřina Staňo, Lenka Radová, Kamila Réblová, et al.. (2018). C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies. International Journal of Hematology. 108(6). 652–657. 5 indexed citations
8.
Procházka, Václav, Tomáš Jonszta, Daniel Czerný, et al.. (2018). The Role of von Willebrand Factor, ADAMTS13, and Cerebral Artery Thrombus Composition in Patient Outcome Following Mechanical Thrombectomy for Acute Ischemic Stroke. Medical Science Monitor. 24. 3929–3945. 37 indexed citations
9.
Kuliha, Martin, Martin Roubec, Eva Hurtíková, et al.. (2016). Laboratory-Based Markers as Predictors of Brain Infarction During Carotid Stenting: a Prospective Study. Journal of Atherosclerosis and Thrombosis. 23(7). 839–847. 8 indexed citations
10.
Šimetka, Ondřej, et al.. (2014). Early identification of women with HELLP syndrome who need plasma exchange after delivery. Transfusion and Apheresis Science. 52(1). 54–59. 14 indexed citations
11.
Procházka, Václav, Jaromír Gumulec, Dana Šalounová, et al.. (2013). Addition of platelet concentrate to Dermo-Epidermal Skin Graft in deep burn trauma reduces scarring and need for revision surgeries. Biomedical Papers. 158(2). 242–258. 14 indexed citations
12.
Plášek, Jiří, et al.. (2012). Resistance to antiplatelet treatment: The clinical relevance of platelet function assays. Cor et Vasa. 54(9-10). e305–e313. 2 indexed citations
13.
Máca, Jan, et al.. (2010). Thrombolysis and cardiac arrest.. PubMed. 111(11). 619–24. 1 indexed citations
14.
Procházka, Václav, Jaromír Gumulec, Dana Šalounová, et al.. (2010). Cell Therapy, a New Standard in Management of Chronic Critical Limb Ischemia and Foot Ulcer. Cell Transplantation. 19(11). 1413–1424. 117 indexed citations
15.
Procházka, Václav, Jaromír Gumulec, Petr Klement, et al.. (2009). Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot.. PubMed. 55(3). 173–8. 31 indexed citations
16.
Brejcha, Martin, et al.. (2009). [Preparation of patients on anticoagulant treatment for invasive surgery].. PubMed. 55(3). 272–5. 1 indexed citations
17.
Gumulec, Jaromír, et al.. (2006). [Prevention of venous thromboembolism: generally accepted guidelines].. PubMed. 52 Suppl 1. 6–16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026